https://www.denverpost.com/2024/03/12/el-chapultepec-historic-preservation-petition-demolition-monfort-companies/
Mar 12, 2024 - Historic Denver this week filed an application for historic protection of the property at 1962 Market St.
0
dp:3892025501115585590
0
https://seekingalpha.com/news/4075588-avadel-drops-after-jury-rules-in-favor-of-jazz-pharmaceuticals-in-patent-dispute?source=feed_sector_healthcare
Mar 04, 2024 - Avadels stock seesawed after a jury ruled in favor of Jazz Pharmaceuticals in a patent dispute over a sleep disorder drug.
0
sa:7681165962457441567
0
https://www.zacks.com/stock/news/2233984/jazz-jazz-q3-earnings-lag-revenues-in-line-with-estimates?cid=CS-ZC-FT-analyst_blog|earnings_article-2233984
Feb 29, 2024 - Jazz's (JAZZ) fourth-quarter earnings miss estimates while sales meet the mark. Shares drop 1.5% post the announcement.
zc:-9127673848086688150
0
https://www.zacks.com/stock/news/2233496/here-s-what-key-metrics-tell-us-about-jazz-jazz-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2233496
Feb 28, 2024 - The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:1610041690898899203
0
https://www.zacks.com/stock/news/2233401/jazz-pharmaceuticals-jazz-q4-earnings-lag-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2233401
Feb 28, 2024 - Jazz (JAZZ) delivered earnings and revenue surprises of -4.56% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
zc:-5044490386142117948
0
https://www.zacks.com/stock/news/2230836/exploring-analyst-estimates-for-jazz-jazz-q4-earnings-beyond-revenue-and-eps?cid=CS-ZC-FT-fundamental_analysis|nfm_preview-2230836
Feb 23, 2024 - Besides Wall Street's top -and-bottom-line estimates for Jazz (JAZZ), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
zc:4358863407234356550
0
https://www.zacks.com/stock/news/2229451/axsome-axsm-stock-falls-despite-q4-earnings-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2229451
Feb 21, 2024 - Axsome (AXSM) stock declines despite narrower-than-expected loss in the fourth quarter of 2023. Its sales also beat estimates.
zc:-7464094320053745154
0
https://www.zacks.com/stock/news/2223497/jazz-boosts-oncology-pipeline-with-kras-inhibitor-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223497
Feb 08, 2024 - JAZZ inks a deal to acquire global rights to Redx Pharma's KRAS inhibitor program to strengthen its early-stage oncology pipeline.
zc:9071132893138823640
0
https://www.nrn.com/regional-chains/swig-named-official-soda-shop-utah-jazz
Feb 06, 2024 - Take note, soda fans: when the ‘jazz win, you win’ with a free swig treat the day after the game
0
nrn:-1505008935341840996
0
https://www.cnbc.com/2024/01/20/former-nba-all-star-danny-ainge-sees-demand-for-international-players.html
Jan 20, 2024 - Utah Jazz CEO Danny Ainge seeks to capitalize on heightened international interest in the NBA.
0
cnbc:-3387680348821787556
0